RNXT Latest Press Releases

-- October 28, 2026 --

RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum Globe Newswire 8:30 AM

-- October 22, 2026 --

RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026 Globe Newswire 8:45 AM

-- October 7, 2026 --

RenovoRx Advances TAMP into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial Globe Newswire 8:30 AM

-- October 1, 2026 --

RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer Globe Newswire 8:30 AM

-- September 2, 2026 --

RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th Globe Newswire 8:30 AM

-- August 25, 2026 --

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP Platform's Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer Globe Newswire 8:30 AM

-- August 21, 2026 --

RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement Globe Newswire 8:30 AM

-- August 20, 2026 --

RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment Globe Newswire 8:30 AM

-- August 12, 2026 --

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth Globe Newswire 4:05 PM

-- August 11, 2026 --

RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer Globe Newswire 8:30 AM

-- August 6, 2026 --

RenovoRx Announces First Commercial Clinical Use of RenovoCath in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors Globe Newswire 8:30 AM

-- August 4, 2026 --

RenovoRx to Highlight TAMP Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th Globe Newswire 8:30 AM

-- July 29, 2026 --

RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET Globe Newswire 8:30 AM

-- June 11, 2026 --

RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP in Locally Advanced Pancreatic Cancer Globe Newswire 8:30 AM

-- June 4, 2026 --

RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes